Analyst Ratings for BioNTech (BNTX)

BNTX Rating Summary

BNTX Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BNTX
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $286.90 (+114%) * Over Last 12-Mos
Rating Score: 2.7 / 10   Percentile Rank: 21%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/1/2022 Redburn Simon Baker Upgrade Neutral
(Sell)
N/A
(N/A)
172.08
(134.04)
-22.11% Details
12/16/2021 Morgan Stanley
» Updated 5/9/2022
Matthew Harrison New Coverage Equalweight
(N/A)
195.00
(197.00)
276.77
(134.04)
-51.57% Details
Like BNTX Ratings? Also take a look at PFE, MRNA, JNJ, NVAX

BNTX Ratings News